Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis

被引:37
作者
Black, Steven [1 ,2 ]
Della Cioppa, Giovanni [3 ]
Malfroot, Anne [4 ]
Nacci, Pantaleo [3 ]
Nicolay, Uwe [5 ]
Pellegrini, Michele [3 ]
Sokal, Etienne [6 ]
Vertruyen, Andre [7 ]
机构
[1] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH 45326 USA
[2] Cincinnati Childrens Hosp, Div Infect Dis, Cincinnati, OH 45326 USA
[3] Novartis Vaccines & Diagnost, Global Clin Res & Dev, Siena, Italy
[4] Univ Ziekenhuis Brussel, Dept Pediat, Clin Pediat Resp Dis Infect Dis & Travel, Cyst Fibrosis Clin, Brussels, Belgium
[5] Novartis Vaccines & Diagnost, Global Clin Res & Dev, Marburg, Germany
[6] Catholic Univ Louvain, Clin St Luc, B-1200 Brussels, Belgium
[7] Sint Vincentiushosp GZA Grp, Dept Pediat, Antwerp, Belgium
关键词
Influenza vaccine; MF59; adjuvant; Children; Adolescents; HEALTHY-CHILDREN; MF59; ADJUVANT; A H1N1; IMMUNOGENICITY; VACCINATION; SQUALENE;
D O I
10.1016/j.vaccine.2010.08.075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We reviewed the safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents (aged 6 months-18 years) in an integrated analysis of all pediatric trials evaluating MF59-containing influenza vaccines completed to date (5 trials). In the MF59-adjuvanted group (n = 1181) versus the non-adjuvanted group (n = 545) there was no increase in the incidence of unsolicited adverse events and serious adverse events. As expected, solicited local or systemic reactions occurred more frequently in MF59-adjuvanted subjects; however, a majority of reactions were mild and transient. These data support the safety of MF59-adjuvanted influenza vaccines in the pediatric population. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7331 / 7336
页数:6
相关论文
共 25 条
[11]   The Global State of Influenza in Children [J].
Esposito, Susanna ;
Marchisio, Paola ;
Principi, Nicola .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (11) :S149-S153
[12]   The rational use of influenza vaccines in healthy children and children with underlying conditions [J].
Esposito, Susanna ;
Principi, Nicola .
CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (03) :244-249
[13]   Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels [J].
Galli, Grazia ;
Medini, Duccio ;
Borgogni, Erica ;
Zedda, Luisanna ;
Bardelli, Monia ;
Malzone, Carmine ;
Nuti, Sandra ;
Tavarini, Simona ;
Sammicheli, Chiara ;
Hilbert, Anne K. ;
Brauer, Volker ;
Banzhoff, Angelika ;
Rappuoli, Rino ;
Del Giudice, Giuseppe ;
Castellino, Flora .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) :3877-3882
[14]   The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes [J].
Holm, BC ;
Svelander, L ;
Bucht, A ;
Lorentzen, JC .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (03) :430-435
[15]   Vaccines for preventing influenza in healthy children [J].
Jefferson, T. ;
Rivetti, A. ;
Harnden, A. ;
Di Pietrantonj, C. ;
Demicheli, V .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02)
[16]   Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada [J].
Kumar, Anand ;
Zarychanski, Ryan ;
Pinto, Ruxandra ;
Cook, Deborah J. ;
Marshall, John ;
Lacroix, Jacques ;
Stelfox, Tom ;
Bagshaw, Sean ;
Choong, Karen ;
Lamontagne, Francois ;
Turgeon, Alexis F. ;
Lapinsky, Stephen ;
Ahern, Stephane P. ;
Smith, Orla ;
Siddiqui, Faisal ;
Jouvet, Philippe ;
Khwaja, Kosar ;
McIntyre, Lauralyn ;
Menon, Kusum ;
Hutchison, Jamie ;
Hornstein, David ;
Joffe, Ari ;
Lauzier, Francois ;
Singh, Jeffrey ;
Karachi, Tim ;
Wiebe, Kim ;
Olafson, Kendiss ;
Ramsey, Clare ;
Sharma, Sat ;
Dodek, Peter ;
Meade, Maureen ;
Hall, Richard ;
Fowler, Robert A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (17) :1872-1879
[17]   Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1) in Argentina [J].
Libster, Romina ;
Bugna, Jimena ;
Coviello, Silvina ;
Hijano, Diego R. ;
Dunaiewsky, Mariana ;
Reynoso, Natalia ;
Cavalieri, Maria L. ;
Guglielmo, Maria C. ;
Soledad Areso, M. ;
Gilligan, Tomas ;
Santucho, Fernanda ;
Cabral, Graciela ;
Gregorio, Gabriela L. ;
Moreno, Rina ;
Lutz, Maria I. ;
Panigasi, Alicia L. ;
Saligari, Liliana ;
Caballero, Mauricio T. ;
Eguees Almeida, Rodrigo M. ;
Gutierrez Meyer, Maria E. ;
Neder, Maria D. ;
Davenport, Maria C. ;
Del Valle, Maria P. ;
Santidrian, Valeria S. ;
Mosca, Guillermina ;
Garcia Dominguez, Mercedes ;
Alvarez, Liliana ;
Landa, Patricia ;
Pota, Ana ;
Bolonati, Norma ;
Dalamon, Ricardo ;
Sanchez Mercol, Victoria I. ;
Espinoza, Marco ;
Carlos Peuchot, Juan ;
Karolinski, Ariel ;
Bruno, Miriam ;
Borsa, Ana ;
Ferrero, Fernando ;
Bonina, Angel ;
Ramonet, Margarita ;
Albano, Lidia C. ;
Luedicke, Nora ;
Alterman, Elias ;
Savy, Vilma ;
Baumeister, Elsa ;
Chappell, James D. ;
Edwards, Kathryn M. ;
Melendi, Guillermina A. ;
Polack, Fernando P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (01) :45-55
[18]   Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons [J].
Minutello, M ;
Senatore, F ;
Cecchinelli, G ;
Bianchi, M ;
Andreani, T ;
Podda, A ;
Crovari, P .
VACCINE, 1999, 17 (02) :99-104
[19]   MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database [J].
Pellegrini, Michele ;
Nicolay, Uwe ;
Lindert, Kelly ;
Groth, Nicola ;
Della Cioppa, Giovanni .
VACCINE, 2009, 27 (49) :6959-6965
[20]  
Principi N, 2003, PEDIATR INFECT DIS J, V22, pS207, DOI 10.1097/01.inf.0000092188.48726.e4